Involvement of matrix metalloproteinase-mediated proteolysis of neural cell adhesion molecule in the development of cerebral ischemic neuronal damage

Kanako Shichi, Wakako Fujita-Hamabe, Shinichi Harada, Hiroyuki Mizoguchi, Kiyofumi Yamada, Toshitaka Nabeshima, Shogo Tokuyama

研究成果: Article

25 引用 (Scopus)

抄録

Neural cell adhesion molecule (NCAM) is a membrane protein abundantly expressed in the central nervous system. Recently, it has been reported that dysfunction of NCAM is linked to human brain disorders. Furthermore, NCAM is one of the proteolysis targets of matrix metalloproteinase (MMP), whose activation is implicated in neuronal damage. The aim of this study was to elucidate the involvement of MMP-mediated proteolysis of NCAM in the development of ischemic neuronal damage. Male ddY and MMP-9 knockout (KO) C57BL/6J mice were subjected to 2 h of middle cerebral artery occlusion (MCAO). In MCAO model mice, development of infarction and behavioral abnormality were clearly observed on days 1 and 3 after MCAO. Protein levels of MMP-2 and MMP-9 were significantly increased on days 1 and 3 after MCAO. In addition, full-length NCAM (180 kDa) was significantly decreased, but its metabolite levels increased on day 1 by ischemic stress per se. NCAM small interfering RNA significantly increased the neuronal damage induced by MCAO. MMP inhibition or MMP-9 gene KO attenuated the infarction, behavioral abnormalities, and decrease of NCAM (180 kDa) observed after MCAO in mice. The present findings clearly suggest that MMP-2/MMP-9-mediated NCAM proteolysis is implicated in the exacerbation of ischemic neuronal damage.

元の言語English
ページ(範囲)701-710
ページ数10
ジャーナルJournal of Pharmacology and Experimental Therapeutics
338
発行部数2
DOI
出版物ステータスPublished - 01-08-2011

Fingerprint

Neural Cell Adhesion Molecules
Matrix Metalloproteinases
Proteolysis
Middle Cerebral Artery Infarction
Matrix Metalloproteinase 9
Matrix Metalloproteinase 2
Infarction
Gene Knockout Techniques
Brain Diseases
Inbred C57BL Mouse
Knockout Mice
Small Interfering RNA
Membrane Proteins
Central Nervous System

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology

これを引用

Shichi, Kanako ; Fujita-Hamabe, Wakako ; Harada, Shinichi ; Mizoguchi, Hiroyuki ; Yamada, Kiyofumi ; Nabeshima, Toshitaka ; Tokuyama, Shogo. / Involvement of matrix metalloproteinase-mediated proteolysis of neural cell adhesion molecule in the development of cerebral ischemic neuronal damage. :: Journal of Pharmacology and Experimental Therapeutics. 2011 ; 巻 338, 番号 2. pp. 701-710.
@article{b1f4e663d83e4aacbb6aefa41f1dd532,
title = "Involvement of matrix metalloproteinase-mediated proteolysis of neural cell adhesion molecule in the development of cerebral ischemic neuronal damage",
abstract = "Neural cell adhesion molecule (NCAM) is a membrane protein abundantly expressed in the central nervous system. Recently, it has been reported that dysfunction of NCAM is linked to human brain disorders. Furthermore, NCAM is one of the proteolysis targets of matrix metalloproteinase (MMP), whose activation is implicated in neuronal damage. The aim of this study was to elucidate the involvement of MMP-mediated proteolysis of NCAM in the development of ischemic neuronal damage. Male ddY and MMP-9 knockout (KO) C57BL/6J mice were subjected to 2 h of middle cerebral artery occlusion (MCAO). In MCAO model mice, development of infarction and behavioral abnormality were clearly observed on days 1 and 3 after MCAO. Protein levels of MMP-2 and MMP-9 were significantly increased on days 1 and 3 after MCAO. In addition, full-length NCAM (180 kDa) was significantly decreased, but its metabolite levels increased on day 1 by ischemic stress per se. NCAM small interfering RNA significantly increased the neuronal damage induced by MCAO. MMP inhibition or MMP-9 gene KO attenuated the infarction, behavioral abnormalities, and decrease of NCAM (180 kDa) observed after MCAO in mice. The present findings clearly suggest that MMP-2/MMP-9-mediated NCAM proteolysis is implicated in the exacerbation of ischemic neuronal damage.",
author = "Kanako Shichi and Wakako Fujita-Hamabe and Shinichi Harada and Hiroyuki Mizoguchi and Kiyofumi Yamada and Toshitaka Nabeshima and Shogo Tokuyama",
year = "2011",
month = "8",
day = "1",
doi = "10.1124/jpet.110.178079",
language = "English",
volume = "338",
pages = "701--710",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

Involvement of matrix metalloproteinase-mediated proteolysis of neural cell adhesion molecule in the development of cerebral ischemic neuronal damage. / Shichi, Kanako; Fujita-Hamabe, Wakako; Harada, Shinichi; Mizoguchi, Hiroyuki; Yamada, Kiyofumi; Nabeshima, Toshitaka; Tokuyama, Shogo.

:: Journal of Pharmacology and Experimental Therapeutics, 巻 338, 番号 2, 01.08.2011, p. 701-710.

研究成果: Article

TY - JOUR

T1 - Involvement of matrix metalloproteinase-mediated proteolysis of neural cell adhesion molecule in the development of cerebral ischemic neuronal damage

AU - Shichi, Kanako

AU - Fujita-Hamabe, Wakako

AU - Harada, Shinichi

AU - Mizoguchi, Hiroyuki

AU - Yamada, Kiyofumi

AU - Nabeshima, Toshitaka

AU - Tokuyama, Shogo

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Neural cell adhesion molecule (NCAM) is a membrane protein abundantly expressed in the central nervous system. Recently, it has been reported that dysfunction of NCAM is linked to human brain disorders. Furthermore, NCAM is one of the proteolysis targets of matrix metalloproteinase (MMP), whose activation is implicated in neuronal damage. The aim of this study was to elucidate the involvement of MMP-mediated proteolysis of NCAM in the development of ischemic neuronal damage. Male ddY and MMP-9 knockout (KO) C57BL/6J mice were subjected to 2 h of middle cerebral artery occlusion (MCAO). In MCAO model mice, development of infarction and behavioral abnormality were clearly observed on days 1 and 3 after MCAO. Protein levels of MMP-2 and MMP-9 were significantly increased on days 1 and 3 after MCAO. In addition, full-length NCAM (180 kDa) was significantly decreased, but its metabolite levels increased on day 1 by ischemic stress per se. NCAM small interfering RNA significantly increased the neuronal damage induced by MCAO. MMP inhibition or MMP-9 gene KO attenuated the infarction, behavioral abnormalities, and decrease of NCAM (180 kDa) observed after MCAO in mice. The present findings clearly suggest that MMP-2/MMP-9-mediated NCAM proteolysis is implicated in the exacerbation of ischemic neuronal damage.

AB - Neural cell adhesion molecule (NCAM) is a membrane protein abundantly expressed in the central nervous system. Recently, it has been reported that dysfunction of NCAM is linked to human brain disorders. Furthermore, NCAM is one of the proteolysis targets of matrix metalloproteinase (MMP), whose activation is implicated in neuronal damage. The aim of this study was to elucidate the involvement of MMP-mediated proteolysis of NCAM in the development of ischemic neuronal damage. Male ddY and MMP-9 knockout (KO) C57BL/6J mice were subjected to 2 h of middle cerebral artery occlusion (MCAO). In MCAO model mice, development of infarction and behavioral abnormality were clearly observed on days 1 and 3 after MCAO. Protein levels of MMP-2 and MMP-9 were significantly increased on days 1 and 3 after MCAO. In addition, full-length NCAM (180 kDa) was significantly decreased, but its metabolite levels increased on day 1 by ischemic stress per se. NCAM small interfering RNA significantly increased the neuronal damage induced by MCAO. MMP inhibition or MMP-9 gene KO attenuated the infarction, behavioral abnormalities, and decrease of NCAM (180 kDa) observed after MCAO in mice. The present findings clearly suggest that MMP-2/MMP-9-mediated NCAM proteolysis is implicated in the exacerbation of ischemic neuronal damage.

UR - http://www.scopus.com/inward/record.url?scp=79960486689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960486689&partnerID=8YFLogxK

U2 - 10.1124/jpet.110.178079

DO - 10.1124/jpet.110.178079

M3 - Article

C2 - 21602423

AN - SCOPUS:79960486689

VL - 338

SP - 701

EP - 710

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 2

ER -